Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 2
2011 5
2012 6
2013 2
2014 6
2015 4
2016 8
2017 4
2018 10
2019 12
2020 9
2021 11
2022 5
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Plasma Androgen Receptor in Prostate Cancer.
Conteduca V, Gurioli G, Brighi N, Lolli C, Schepisi G, Casadei C, Burgio SL, Gargiulo S, Ravaglia G, Rossi L, Altavilla A, Farolfi A, Menna C, Colangione SP, Pulvirenti M, Romeo A, De Giorgi U. Conteduca V, et al. Among authors: lolli c. Cancers (Basel). 2019 Nov 4;11(11):1719. doi: 10.3390/cancers11111719. Cancers (Basel). 2019. PMID: 31689899 Free PMC article. Review.
Taxane-related nail toxicity.
Schepisi G, Conteduca V, Lolli C, Medri M, De Giorgi U. Schepisi G, et al. Among authors: lolli c. Lancet Oncol. 2015 Jul;16(7):e310-1. doi: 10.1016/S1470-2045(15)00019-4. Lancet Oncol. 2015. PMID: 26149877 No abstract available.
Psychosocial Issues in Long-Term Survivors of Testicular Cancer.
Schepisi G, De Padova S, De Lisi D, Casadei C, Meggiolaro E, Ruffilli F, Rosti G, Lolli C, Ravaglia G, Conteduca V, Farolfi A, Grassi L, De Giorgi U. Schepisi G, et al. Among authors: lolli c. Front Endocrinol (Lausanne). 2019 Feb 25;10:113. doi: 10.3389/fendo.2019.00113. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30858829 Free PMC article. Review.
Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer.
Altavilla A, Casadei C, Lolli C, Menna C, Ravaglia G, Gurioli G, Farolfi A, Brighi N, Conteduca V, Burgio SL, Schepisi G, Rossi L, Gargiulo S, Lisotti I, De Giorgi U. Altavilla A, et al. Among authors: lolli c. Expert Opin Pharmacother. 2020 Dec;21(17):2091-2099. doi: 10.1080/14656566.2020.1803281. Epub 2020 Aug 12. Expert Opin Pharmacother. 2020. PMID: 32783772 Review.
CAR-T cell therapy: a potential new strategy against prostate cancer.
Schepisi G, Cursano MC, Casadei C, Menna C, Altavilla A, Lolli C, Cerchione C, Paganelli G, Santini D, Tonini G, Martinelli G, De Giorgi U. Schepisi G, et al. Among authors: lolli c. J Immunother Cancer. 2019 Oct 16;7(1):258. doi: 10.1186/s40425-019-0741-7. J Immunother Cancer. 2019. PMID: 31619289 Free PMC article. Review.
Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors.
Schepisi G, Gianni C, Cursano MC, Gallà V, Menna C, Casadei C, Bleve S, Lolli C, Martinelli G, Rosti G, De Giorgi U. Schepisi G, et al. Among authors: lolli c. Front Immunol. 2023 Feb 13;14:1118610. doi: 10.3389/fimmu.2023.1118610. eCollection 2023. Front Immunol. 2023. PMID: 36860862 Free PMC article. Review.
83 results